Tragic revelations, made Friday by authorities in New Mexico, resolve many questions raised by the deaths of Gene Hackman and ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Researchers in the current study designed a dual-function recombinant adeno-associated virus serotype 9 vector to deliver ... as a therapeutic alternative to prescription diet and liver transplant ...

Choose from Picking Up Prescription stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

Researchers in the current study designed a dual-function recombinant adeno-associated virus serotype 9 vector to deliver ... as a therapeutic alternative to prescription diet and liver transplant ...

Choose from Prescription Medicine stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Researchers in the current study designed a dual-function recombinant adeno-associated virus serotype 9 vector to deliver ... as a therapeutic alternative to prescription diet and liver transplant ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...